Disease activity state by ASDAS-CRP vs. ASDAS-qCRP (A) and ASDAS-CRP

Change in HAQ-S and SF-36 PCS by ASDAS classification Change in least

PDF) Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?

PDF) The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry

The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry - Jinhyun Kim, Min Jung Kim, Geun Young Oh, Sun Kyung Lee

PDF) Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study

Discrimination: standardized mean difference in ASDAS scores between

Disease activity state by ASDAS-CRP vs. ASDAS-qCRP (A) and ASDAS-CRP

PDF) Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study

Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study

Change from baseline to week 12 in patient-reported outcomes by ASDAS